BlackRock Amends Harmony Bio Stake, Holds 5.47M Shares
Ticker: HRMY · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 1802665
| Field | Detail |
|---|---|
| Company | Harmony Biosciences Holdings, INC. (HRMY) |
| Form Type | SC 13G/A |
| Filed Date | Jan 24, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, pharmaceuticals
TL;DR
**BlackRock still owns a huge chunk of Harmony Bio, signaling confidence.**
AI Summary
BlackRock Inc. filed an amended Schedule 13G/A on January 24, 2024, disclosing its ownership in Harmony Biosciences Holdings, Inc. As of December 31, 2023, BlackRock, a major institutional investor, reported holding 5,471,069 shares of Harmony Biosciences' Common Stock. This represents a significant stake, indicating BlackRock's continued confidence in the pharmaceutical company, which could be a positive signal for current and prospective investors.
Why It Matters
This filing shows BlackRock's updated position in Harmony Biosciences, signaling their ongoing investment strategy and potentially influencing other investors' perceptions of the stock.
Risk Assessment
Risk Level: low — This filing is a routine update from a major institutional investor and does not indicate any immediate negative risks.
Analyst Insight
Investors should note BlackRock's continued substantial holding in Harmony Biosciences as a potential indicator of institutional confidence, but conduct their own due diligence before making investment decisions.
Key Numbers
- 5,471,069 — Shares Held (The total number of Harmony Biosciences Common Stock shares BlackRock Inc. beneficially owned as of December 31, 2023.)
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Harmony Biosciences Holdings, Inc. (company) — the subject company whose shares are being reported
- 5,471,069 (dollar_amount) — the number of shares of Common Stock held by BlackRock Inc.
- December 31, 2023 (date) — the date of the event which required the filing
Forward-Looking Statements
- BlackRock will maintain a significant stake in Harmony Biosciences throughout 2024. (BlackRock Inc.) — medium confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under the Securities Exchange Act of 1934.
Who is the reporting person in this filing?
The reporting person is BlackRock Inc., a major institutional investment manager.
What is the subject company of this filing?
The subject company is Harmony Biosciences Holdings, Inc., a pharmaceutical preparations company.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023.
What is the CUSIP number for the securities mentioned?
The CUSIP number for the Common Stock of Harmony Biosciences Holdings, Inc. is 413197104.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding Harmony Biosciences Holdings, Inc. (HRMY).